Abstract
A 52-year-old postmenopausal woman presented with an abnormal screening mammogram showing a suspicious area in the upper outer quadrant of her left breast. [...]
Highlights
This patient was offered fluorouracil, epirubicin, and cyclophosphamide followed by docetaxel adjuvant chemotherapy
Many advances have been made in adjuvant therapy for early-stage breast cancer, contributing to an overall decline in mortality
One major advance has been the addition of taxanes, either concurrently with or sequentially to anthracycline-based adjuvant chemotherapy
Summary
This patient was offered fluorouracil, epirubicin, and cyclophosphamide followed by docetaxel adjuvant chemotherapy. How can the potential toxicities of this adjuvant chemotherapy regimen be optimally managed? Many advances have been made in adjuvant therapy for early-stage breast cancer, contributing to an overall decline in mortality. One major advance has been the addition of taxanes, either concurrently with or sequentially to anthracycline-based adjuvant chemotherapy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
